EMA’s quality innovation group helps to propel regulatory path for novel technologies
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)EuropeMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development